Envara Health is committed to making significant advancements in the field of medical nutrition. Our goal is to provide clinically proven, medically innovative products that enable better outcomes for the people we serve. Founded in 2017 by Dr. Virginia Stallings, MD and Jim O’Connell, Envara Health has assembled a team of highly successful life science industry veterans with extensive commercialization and manufacturing experience to lead the company’s first product launch of Encala™. Encala was tested in a large NIH funded clinical study at 10 Certified Cystic Fibrosis Centers and found safe and effective. Invented by the late Dr. David Yesair, PhD, an internationally recognized biochemist, and patented under the original registered trademark, Lym-X-Sorb®, Encala™ was inspired by and developed for patients with cystic fibrosis who struggle with malabsorption. Envara Health is built for growth as our base formulation has applications across a broad spectrum of disease states in both humans and animals.